Anti-COVID Drug ‘Colchicine’ Cleared for Phase 2 Clinical Trials
Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the regulatory approval by the Drugs Controller General of India (DCGI) to undertake a two-arm phase-II clinical trial to…
Read More...
Read More...